Isan Chen

2015

In 2015, Isan Chen earned a total compensation of $1M as Executive Vice President and Chief Medical and Development Officer at Mirati Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$130,900
Option Awards$525,600
Salary$384,779
Other$2,814
Total$1,044,093

Chen received $525.6K in option awards, accounting for 50% of the total pay in 2015.

Chen also received $130.9K in non-equity incentive plan, $384.8K in salary and $2.8K in other compensation.

Rankings

In 2015, Isan Chen's compensation ranked 7,743rd out of 13,638 executives tracked by ExecPay. In other words, Chen earned more than 43.2% of executives.

ClassificationRankingPercentile
All
7,743
out of 13,638
43rd
Division
Manufacturing
2,935
out of 5,187
43rd
Major group
Chemicals And Allied Products
1,059
out of 1,857
43rd
Industry group
Drugs
855
out of 1,531
44th
Industry
Pharmaceutical Preparations
671
out of 1,179
43rd
Source: SEC filing on April 20, 2017.

Chen's colleagues

We found three more compensation records of executives who worked with Isan Chen at Mirati Therapeutics in 2015.

2015

Charles Baum

Mirati Therapeutics

Chief Executive Officer

2015

Mark Gergen

Mirati Therapeutics

Former Executive Vice President and Chief Operations Officer

2015

James Christensen

Mirati Therapeutics

Chief Scientific Officer

News

In-depth

You may also like